When was Dash Bio founded?

Dash Bio was founded in 2024 and raised its 1st funding round within a year of its incorporation.

Where is Dash Bio located?

Dash Bio is headquartered in Boston, United States.

Who is the current CEO of Dash Bio?

Dave Johnson of Dash Bio. They have also founded 1 company.

How many employees does Dash Bio have?

As of Aug 31, 2026, the latest employee count at Dash Bio is 43.

Is Dash Bio a funded company?

Dash Bio is a funded company, having raised a total of $47.5M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Oct 02, 2024.

When was the latest funding round of Dash Bio?

Dash Bio's latest funding was a $***** Series A round on Jun 15, 2026, with participation from 3 investors. Its primary sector is Biopharma Outsourcing. In United States, the Biopharma Outsourcing sector has seen $749M in funding in 2026 to date.

Where does Dash Bio rank among its competitors?

Dash Bio ranks 4th amongst 366 active competitors, of which 15 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Dash Bio, which secured $30M in Jun, 2026.

Who are the top competitors of Dash Bio?

Dash Bio's top competitors include Solvias, Clean Cells and Advion. Among them, Dash Bio secured the most recent funding round in June, 2026.

Dash Bio - 2026 Company Profile, Team, Funding & Competitors

Dash Bio is a series A company based in Boston (United States), founded in 2024 by Ander Tallett and Dave Johnson. It operates as a Provider of automated bioanalysis platform for accelerated clinical drug development. Dash Bio has raised $47.5M in funding from investors like Freestyle, Oak HC/FT and The Aligned Fund. The company has 366 active competitors, including 15 funded and 88 that have exited. Its top competitors include companies like Solvias, Clean Cells and Advion.

Company Details

Provider of automated bioanalysis platform for accelerated clinical drug development. It leverages AI and robotics to deliver high-quality assays with faster turnaround times for clinical trials and GLP studies. The company automates critical steps in bioanalysis, reducing costs and time to market. It focuses on clinical bioanalysis, specifically the testing of samples from clinical trial subjects. The platform integrates quality, automation, and regulatory compliance to enhance customer experience and outcomes.

Website: www.dash.bio/
Email ID: *****@dash.bio
Phone Number: +1 **********

Key Metrics

Founded Year

2024

Location

Boston, United States

Stage

Series A

Total Funding

$47.5M in 3 rounds

Latest Funding Round

Series A, Jun 15, 2026, $*****

Investors

Freestyle & 8 more

Ranked

4^th among 366 active competitors

Employee Count

43 as on Aug 31, 2026

Similar Companies

Solvias & 399 more

View Dash Bio's full profile

Dash Bio has raised a total funding of $47.5M over 3 rounds. Its first funding round was on Oct 02, 2024. Its latest funding round was a Series A round on Jun 15, 2026 for $*****. 3 investors participated in its latest round. Dash Bio has 7 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of Dash Bio:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 15, 2026	1681393	Series A	7984472	9782505	2377119	4220014
Jun 13, 2025	1236811	Series A	2230067	1087495	8850803	Freestyle & 4 more
Oct 02, 2024	7309736	Seed	5842784	8802442	Freestyle	Swift Ventures & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of Dash Bio's funding rounds and investors

The founders of Dash Bio are Ander Tallett and Dave Johnson. Dave Johnson is the CEO of Dash Bio.

Here are the details of Dash Bio's key team members:

Ander Tallett: Co-Founder & COO of Dash Bio.
Dave Johnson: Co-founder & CEO of Dash Bio.

View details of Dash Bio's Founder profiles and Board Members

Dash Bio's employee count trend

Dash Bio has 43 employees as of Aug 26. Here is Dash Bio's employee count trend over the years:

Uncover Dash Bio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Dash Bio include Solvias, Clean Cells and Advion. Here is the list of Top 10 competitors of Dash Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Solvias 1999, Kaiseraugst (Switzerland), Acquired	Developer and manufacturer of medical devices, cosmetics, agrochemicals, and chemicals	-	Water Street, Broadoak Capital Partners & 1 others	54/100
2nd	Clean Cells 2000, Bouffere (France), Acquired	Offers cell banking and virus banking services	-	-	53/100
3rd	Advion 1993, Ithaca (United States), Acquired	Mass spectrometry, chromatography, and purification solutions for scientific advancement	$45.6M	Gefinor Capital, Aisling Capital & 3 others	51/100
4th	Dash Bio 2024, Boston (United States), Series A	Provider of automated bioanalysis platform for accelerated clinical drug development	$47.5M	Oak HC/FT, Swift Ventures & 7 others	50/100
5th	Nucro-Technics 1970, Scarborough (Canada), Acquired	Full-service bioanalytical CRO offering toxicity, bioanalytical and stability study services	-	-	47/100
6th	Teena Biolabs 1999, Hyderabad (India), Acquired	Testing laboratory offering pharmacopeial tests, calibration & validation services	-	-	46/100
7th	Evans Analytical Group 1978, San Diego (United States), Acquired	Materials testing and engineering sciences, accelerating innovation through multidisciplinary expertise	-	Odyssey Investment Partners, Riverside & 1 others	46/100
8th	BioAgilytix 2008, Durham (United States), Acquired	Global bioanalytical services leader, supporting drug development across various modalities	-	GHO Capital Partners, Caledonia Private Capital ... & 2 others	46/100
9th	Nordic Bioscience 1996, Herlev (Denmark), Late Stage	Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform	-	KKR, Europa	46/100
10th	Sitec Labs 2004, Mumbai (India), Unfunded	CRO offering bioequivalence and bioanalytical services	-	-	45/100